Syndax Pharmaceuticals Inc SEC filings SNDX

Syndax Pharmaceuticals Inc has 657 filings in SEC EDGAR's recent list, going back to Apr 6, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Syndax Pharmaceuticals Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations, Officer or director change
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Other events
Jul 14, 2026 Jul 14, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Jun 10, 2026 Jun 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 10, 2026 Jun 10, 2026
DEFA14A Additional proxy material Jun 4, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 4, 2026 Jun 3, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Bylaw or fiscal year change
Dec 19, 2025 Dec 18, 2025
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 24, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 4, 2025 Aug 4, 2025
8-K Current report
Officer or director change
Jun 26, 2025 Jun 24, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
May 16, 2025 May 12, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 1, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 1, 2025 —
DEF 14A Proxy statement Apr 1, 2025 Apr 1, 2025
S-8 Employee stock plan registration Mar 4, 2025 —
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations, Other events
Mar 3, 2025 Mar 3, 2025
8-K Current report
Officer or director change
Dec 20, 2024 Dec 20, 2024
8-K Current report
Other events
Nov 18, 2024 Nov 15, 2024
8-K Current report
Other events
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
8-K Current report
Material agreement
Nov 4, 2024 Nov 4, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
May 15, 2024 May 14, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 2, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 2, 2024 —
DEF 14A Proxy statement Apr 2, 2024 Mar 27, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 18, 2024 Mar 15, 2024
S-3ASR Automatic shelf registration Feb 27, 2024 —
S-8 Employee stock plan registration Feb 27, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Other events
Dec 20, 2023 Dec 19, 2023
8-K Current report
Material agreement
Dec 15, 2023 Dec 14, 2023
424B5 Prospectus supplement Dec 15, 2023 —
424B5 Prospectus supplement Dec 14, 2023 —
8-K Current report
Other events
Dec 12, 2023 Dec 10, 2023
UPLOAD Letter from the SEC Dec 7, 2023 —
CORRESP Letter to the SEC Nov 28, 2023 —
UPLOAD Letter from the SEC Nov 13, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Other events
Jul 24, 2023 Jul 24, 2023
8-K Current report
Agreement ended, Other events
May 26, 2023 May 26, 2023
424B5 Prospectus supplement May 26, 2023 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
May 18, 2023 May 17, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Officer or director change
May 8, 2023 May 5, 2023
DEFA14A Additional proxy material Apr 18, 2023 —
ARS Annual report to shareholders Apr 7, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 7, 2023 —
DEF 14A Proxy statement Apr 7, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 30, 2023 Mar 29, 2023
PRE 14A Preliminary proxy statement Mar 28, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Officer or director change
Feb 8, 2023 Feb 2, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Dec 14, 2022 Dec 14, 2022
8-K Current report
Material agreement
Dec 7, 2022 Dec 6, 2022
424B5 Prospectus supplement Dec 7, 2022 —
424B5 Prospectus supplement Dec 6, 2022 —
8-K Current report
Officer or director change
Dec 5, 2022 Dec 1, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Agreement ended, Regulation FD disclosure
Sep 23, 2022 Sep 19, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Officer or director change
Jun 13, 2022 Jun 8, 2022
8-K Current report
Shareholder vote results
May 11, 2022 May 11, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
DEFA14A Additional proxy material Mar 30, 2022 —
DEF 14A Proxy statement Mar 29, 2022 May 11, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Mar 1, 2022 Mar 1, 2022
8-K Current report
Officer or director change
Feb 24, 2022 Feb 22, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 3, 2022 Feb 2, 2022
8-K Current report
Material agreement, New debt
Dec 23, 2021 Dec 22, 2021
8-K Current report
Material agreement
Dec 17, 2021 Dec 15, 2021
424B5 Prospectus supplement Dec 17, 2021 —
424B5 Prospectus supplement Dec 16, 2021 —
8-K Current report
Other events
Dec 13, 2021 Dec 11, 2021
8-K Current report
Other events
Dec 9, 2021 Dec 9, 2021
424B5 Prospectus supplement Dec 9, 2021 —
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Officer or director change
Oct 4, 2021 Oct 4, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Sep 27, 2021 Sep 24, 2021
8-K Current report
Officer or director change
Sep 15, 2021 Sep 15, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
S-8 Employee stock plan registration Aug 9, 2021 —
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Shareholder vote results
May 13, 2021 May 13, 2021
10-Q Quarterly report May 11, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
10-K/A Amended annual report Apr 30, 2021 Dec 31, 2020
DEF 14A Proxy statement Apr 1, 2021 May 13, 2021
S-3ASR Automatic shelf registration Mar 24, 2021 —
RW Filing Mar 24, 2021 —
S-3 Shelf registration Mar 22, 2021 —
10-K Annual report Mar 12, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 8, 2021 Mar 8, 2021
8-K Current report
Officer or director change
Feb 5, 2021 Feb 3, 2021
8-K Current report
Material agreement
Dec 9, 2020 Dec 8, 2020
424B5 Prospectus supplement Dec 9, 2020 —
8-K Current report
Agreement ended, Other events
Dec 7, 2020 Dec 7, 2020
424B5 Prospectus supplement Dec 7, 2020 —
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 2, 2020 Nov 2, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
S-8 Employee stock plan registration Aug 6, 2020 —
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change
Jul 7, 2020 Jul 6, 2020
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 9, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
8-K Current report
Material agreement, Other events
May 4, 2020 Apr 30, 2020
424B5 Prospectus supplement May 4, 2020 —
8-K Current report
Results of operations, Other events
Apr 30, 2020 Apr 30, 2020
424B5 Prospectus supplement Apr 30, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 9, 2020
10-K Annual report Mar 5, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 3, 2020 Mar 3, 2020
8-K Current report
Officer or director change
Feb 20, 2020 Feb 12, 2020
8-K Current report
Material agreement, New debt
Feb 10, 2020 Feb 7, 2020
8-K Current report
Other events
Feb 4, 2020 Jan 30, 2020
424B5 Prospectus supplement Feb 3, 2020 —
8-K Current report
Other events
Dec 10, 2019 Dec 10, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Regulation FD disclosure
Oct 7, 2019 Oct 7, 2019
EFFECT Filing Sep 10, 2019 —
424B5 Prospectus supplement Sep 10, 2019 —
CORRESP Letter to the SEC Sep 6, 2019 —
UPLOAD Letter from the SEC Sep 5, 2019 —
S-3 Shelf registration Aug 30, 2019 —
S-8 Employee stock plan registration Aug 7, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Officer or director change
Jul 8, 2019 Jul 4, 2019
8-K Current report
Shareholder vote results
Jun 11, 2019 Jun 10, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 6, 2019 May 6, 2019
DEF 14A Proxy statement Apr 30, 2019 Jun 10, 2019
424B5 Prospectus supplement Mar 29, 2019 —
8-K Current report
Other events
Mar 29, 2019 Mar 26, 2019
CT ORDER Filing Mar 28, 2019 —
424B5 Prospectus supplement Mar 28, 2019 —
10-K/A Amended annual report Mar 18, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 7, 2019 Mar 7, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Officer or director change
Feb 12, 2019 Feb 6, 2019
CT ORDER Filing Dec 20, 2018 —
CT ORDER Filing Nov 27, 2018 —
10-Q Quarterly report Nov 5, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 5, 2018 Nov 5, 2018
8-K Current report
Officer or director change, Other events
Sep 26, 2018 Sep 24, 2018
CT ORDER Filing Aug 29, 2018 —
S-8 Employee stock plan registration Aug 8, 2018 —
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
8-K Current report
Unregistered share sale
Jun 20, 2018 Jun 18, 2018
CT ORDER Filing Jun 13, 2018 —
8-K Current report
Shareholder vote results
May 25, 2018 May 23, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 8, 2018 May 8, 2018
DEFA14A Additional proxy material Apr 10, 2018 —
DEF 14A Proxy statement Apr 10, 2018 May 23, 2018
CT ORDER Filing Apr 3, 2018 —
10-K Annual report Mar 8, 2018 Dec 31, 2017
8-K Current report
Officer or director change
Mar 6, 2018 Mar 1, 2018
8-K Current report
Results of operations
Mar 5, 2018 Mar 5, 2018
10-Q Quarterly report Nov 8, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 7, 2017 Nov 7, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SNDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1395937

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.